牛是一种潜在的治疗类风湿性关节炎通过向FOXO3通过细胞衰老和自的治疗方法
Qingcong Zheng1, Rongjie Lin2, Zhechen Li1
1Department of Spinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
PloS one
|April 16, 2025
概括
这项研究确定了MMP9,CXCL10,IL15和FOXO3作为类风湿性关节炎 (RA),细胞衰老和自的关键生物标志物. 氨酸通过FOXO3.3针对这些途径显示出作为RA治疗的潜力.
科学领域:
- 生物医学研究的研究.
- 计算生物学是一种计算生物学.
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性关节炎 (RA) 是一种与衰老相关的慢性自身免疫性疾病,其原因尚不完全理解.
- 确定RA,衰老和自的可靠生物标志物对于了解疾病机制至关重要.
研究的目的:
- 用生物信息学和机器学习来识别RA,衰老和自的新生物标志物.
- 通过使用计算机辅助药物设计 (CADD) 探索氨酸与标蛋白的相互作用,研究氨酸在RA中的治疗潜力.
主要方法:
- 差异性基因表达分析和对RA,衰老和自的基因组丰富.
- 应用机器学习算法 (SVM-RFE,ANN,LASSO,WGCNA) 来识别关键基因.
- 微RNA/转录因子网络的生物信息分析,途径丰富和免疫细胞透.
- 分子对接和动力学模拟以评估牛蛋白结合稳定性,通过体外实验验证实.
主要成果:
- 确定了74个与RA相关的常见基因 (共基因),细胞衰老和编程细胞死亡.
- 关键基因 (MMP9,CXCL10,IL15,FOXO3) 在接收器操作特征 (ROC) 分析中显示出高诊断效率.
- 在RA中,FOXO3表达下调,与上调的MMP9,CXCL10和IL15相反相关.
- 氨酸证明与FOXO3稳定结合,体外实验证实其提高FOXO3调节的能力,这表明通过FOXO3-帕金通路的治疗机制.
结论:
- MMP9,CXCL10,IL15和FOXO3是RA,细胞衰老和自的验证生物标志物.
- 氨酸作为一种潜在的RA治疗剂而出现,通过调节FOXO3通路来准细胞衰老和自.
相关概念视频
01:24T Cell Types and Functions
633
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
633
01:20The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
01:22PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K